Advertisement
Home Tags Therapy & Procedures: Misc.

Tag: Therapy & Procedures: Misc.

For patients with acute ischemic stroke undergoing intravenous thrombolysis

Remote Ischemic Postconditioning May Aid Stroke Recovery

0
More patients with acute ischemic stroke in RIPC group had excellent recovery at three months
Fecal microbiota transplantation is effective for Clostridium difficile infection through six months and has a good safety profile

Fecal Transplant Safe, Effective for C. Difficile Through Six Months

0
90 percent of those undergoing FMT had one-month cure; 4 percent had recurrence within six months
Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention

CYP2C19 Genotyping May Aid Antiplatelet Prescribing

0
Benefit only seen for composite outcome, not for major or minor bleeding incidents
There is no evidence to support the use of convalescent plasma to treat COVID-19 patients

No Proof Convalescent Plasma Effective Against COVID-19

0
NIH panel says data are insufficient to recommend either for or against the use of convalescent plasma
The use of blood plasma from COVID-19 survivors to treat patients hospitalized with the disease is still considered experimental

WHO: Plasma Therapy for COVID-19 Still Experimental

0
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
The U.S. Food and Drug Administration on Sunday cleared the way for more hospitalized COVID-19 patients to be treated with the blood plasma of COVID-19 survivors.

FDA Approves Wider Use of Plasma as COVID-19 Treatment

0
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
The U.S. Food and Drug Administration emergency approval of blood plasma as a COVID-19 treatment was put on hold last week after senior federal health officials said data supporting the therapy were too weak.

FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19

0
More data are under review; the approval could still be issued in the near future
Existing evidence on the diagnostic accuracy of serological tests for COVID-19 is characterized by high risks of bias and heterogeneity

Evidence Poor for Accuracy of Serological Tests for COVID-19

0
Evidence for diagnostic accuracy of serological tests characterized by high risks of bias, heterogeneity
Convalescent plasma seems safe for COVID-19 patients based on data from the first 20

Convalescent Plasma Safe for Diverse Patients With COVID-19

0
Incidence of SAEs, including transfusion reactions, thromboembolic or thrombotic events, is low
Pooled data from recent studies show that women with acute stroke are less likely to be treated with intravenous thrombolysis compared with men

Treatment Gap Remains in Stroke Care Between Men and Women

0
Size of this difference has narrowed compared with studies published before 2008